A new purification technique to obtain specific size distribution of giant lipid vesicles using dual filtration.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
05
2021
accepted:
07
07
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
4
11
2021
Statut:
epublish
Résumé
A new purification technique is developed for obtaining distribution of giant unilamellar vesicles (GUVs) within a specific range of sizes using dual filtration. The GUVs were prepared using well known natural swelling method. For filtration, different combinations of polycarbonate membranes were implemented in filter holders. In our experiment, the combinations of membranes were selected with corresponding pore sizes-(i) 12 and 10 μm, (ii) 12 and 8 μm, and (iii) 10 and 8 μm. By these filtration arrangements, obtained GUVs size distribution were in the ranges of 6-26 μm, 5-38 μm and 5-30 μm, respectively. In comparison, the size distribution range was much higher for single filtration technique, for example, 6-59 μm GUVs found for a membrane with 12 μm pores. Using this technique, the water-soluble fluorescent probe, calcein, can be removed from the suspension of GUVs successfully. The size distributions were analyzed with lognormal distribution. The skewness became smaller (narrow size distribution) when a dual filtration was used instead of single filtration. The mode of the size distribution obtained in dual filtration was also smaller to that of single filtration. By continuing this process of purification for a second time, the GUVs size distribution became even narrower. After using an extra filtration with dual filtration, two different size distributions of GUVs were obtained at a time. This experimental observation suggests that different size specific distributions of GUVs can be obtained easily, even if GUVs are prepared by different other methods.
Identifiants
pubmed: 34324548
doi: 10.1371/journal.pone.0254930
pii: PONE-D-21-16232
pmc: PMC8321220
doi:
Substances chimiques
Fluoresceins
0
Phosphatidylcholines
0
Unilamellar Liposomes
0
fluorexon
V0YM2B16TS
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0254930Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Eur Biophys J. 2019 May;48(4):349-359
pubmed: 30918998
Integr Biol (Camb). 2018 Jan 22;10(1):6-17
pubmed: 29230464
Clin Cancer Res. 2004 Apr 1;10(7):2319-26
pubmed: 15073107
New J Phys. 2011 Sep 16;13:
pubmed: 21966242
Sci Rep. 2015 Oct 16;5:15369
pubmed: 26471872
Chem Phys Lipids. 2020 Aug;230:104916
pubmed: 32407734
J Appl Physiol (1985). 1998 Aug;85(2):379-85
pubmed: 9688708
Biophys J. 1981 Sep;35(3):637-52
pubmed: 7272454
J Am Chem Soc. 2009 Oct 14;131(40):14158-9
pubmed: 19775107
Phys Chem Chem Phys. 2014 Aug 14;16(30):15752-67
pubmed: 24965206
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
Biophys Rev. 2020 Apr;12(2):339-348
pubmed: 32152921
Chem Phys Lipids. 2011 Jul;164(5):351-8
pubmed: 21524642
Eur Phys J E Soft Matter. 2021 Apr 28;44(4):62
pubmed: 33909146
Eur Biophys J. 2019 Dec;48(8):731-741
pubmed: 31552440
J Pharm Sci. 2001 Jun;90(6):667-80
pubmed: 11357170
J Phys Chem B. 2009 Apr 9;113(14):4846-52
pubmed: 19267489
PLoS One. 2018 Feb 16;13(2):e0192975
pubmed: 29451909
Respir Care. 2004 Jun;49(6):666-77
pubmed: 15165301
J Phys Chem B. 2010 Sep 23;114(37):12018-26
pubmed: 20799752
J Cell Physiol. 1969 Feb;73(1):49-60
pubmed: 5765779
Biophys J. 2016 Nov 15;111(10):2190-2201
pubmed: 27851942
Trends Pharmacol Sci. 2009 Nov;30(11):592-9
pubmed: 19837467
Biochim Biophys Acta. 2002 Aug 19;1564(1):173-82
pubmed: 12101010
Chembiochem. 2010 May 3;11(7):848-65
pubmed: 20336703
Biochemistry. 2005 Dec 6;44(48):15823-33
pubmed: 16313185
J Phys Chem B. 2020 Jul 9;124(27):5588-5599
pubmed: 32543195
Eur Biophys J. 2020 Jul;49(5):371-381
pubmed: 32494845
PLoS One. 2021 May 14;16(5):e0251690
pubmed: 33989363
Biophys J. 2000 Jul;79(1):328-39
pubmed: 10866959
PLoS One. 2009;4(4):e5009
pubmed: 19347043
Adv Drug Deliv Rev. 2013 Jan;65(1):36-48
pubmed: 23036225
Phys Rev E. 2020 Jan;101(1-1):012404
pubmed: 32069606